151 related articles for article (PubMed ID: 15146583)
1. [Genetics and physiopathology of primary or secondary pulmonary artery hypertension].
Adnot S; Eddahibi S
Bull Acad Natl Med; 2003; 187(8):1529-42; discussion 1543-5. PubMed ID: 15146583
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.
Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S
Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of pulmonary arterial hypertension.
Eddahibi S; Morrell N; d'Ortho MP; Naeije R; Adnot S
Eur Respir J; 2002 Dec; 20(6):1559-72. PubMed ID: 12503718
[TBL] [Abstract][Full Text] [Related]
4. Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
Humbert M; Labrune P; Simonneau G
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S93-6. PubMed ID: 12373580
[TBL] [Abstract][Full Text] [Related]
5. The serotonin pathway in pulmonary hypertension.
Eddahibi S; Adnot S
Arch Mal Coeur Vaiss; 2006 Jun; 99(6):621-5. PubMed ID: 16878724
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.
Eddahibi S; Humbert M; Fadel E; Raffestin B; Darmon M; Capron F; Simonneau G; Dartevelle P; Hamon M; Adnot S
J Clin Invest; 2001 Oct; 108(8):1141-50. PubMed ID: 11602621
[TBL] [Abstract][Full Text] [Related]
7. Primary pulmonary hypertension: molecular basis and potential for therapy.
Rudarakanchana N; Morrell NW
Expert Rev Mol Med; 2004 Mar; 6(6):1-15. PubMed ID: 15005857
[TBL] [Abstract][Full Text] [Related]
8. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary arterial hypertension and BMP system abnormality].
Otsuka F
Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
[TBL] [Abstract][Full Text] [Related]
12. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
13. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.
Eddahibi S; Guignabert C; Barlier-Mur AM; Dewachter L; Fadel E; Dartevelle P; Humbert M; Simonneau G; Hanoun N; Saurini F; Hamon M; Adnot S
Circulation; 2006 Apr; 113(15):1857-64. PubMed ID: 16606791
[TBL] [Abstract][Full Text] [Related]
14. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension.
Machado RD; Rudarakanchana N; Atkinson C; Flanagan JA; Harrison R; Morrell NW; Trembath RC
Hum Mol Genet; 2003 Dec; 12(24):3277-86. PubMed ID: 14583445
[TBL] [Abstract][Full Text] [Related]
16. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma activation: a potential treatment for pulmonary hypertension.
Hansmann G; Zamanian RT
Sci Transl Med; 2009 Dec; 1(12):12ps14. PubMed ID: 20371457
[TBL] [Abstract][Full Text] [Related]
18. Improved right ventricular-vascular coupling during active pulmonary hypertension.
Grignola JC; Ginés F; Bia D; Armentano R
Int J Cardiol; 2007 Feb; 115(2):171-82. PubMed ID: 16797089
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of the serotonin transporter in pulmonary arterial hypertension.
Machado RD; Koehler R; Glissmeyer E; Veal C; Suntharalingam J; Kim M; Carlquist J; Town M; Elliott CG; Hoeper M; Fijalkowska A; Kurzyna M; Thomson JR; Gibbs SR; Wilkins MR; Seeger W; Morrell NW; Gruenig E; Trembath RC; Janssen B
Am J Respir Crit Care Med; 2006 Apr; 173(7):793-7. PubMed ID: 16399993
[TBL] [Abstract][Full Text] [Related]
20. Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failure.
Olson TP; Snyder EM; Frantz RP; Turner ST; Johnson BD
Am Heart J; 2007 Mar; 153(3):426-32. PubMed ID: 17307423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
